These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 5357297)
1. [The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis]. Caruzzo C; Carnaghi R; Enrico-Bena L; De Marco G Minerva Med; 1969 Nov; 60(91):4514-8. PubMed ID: 5357297 [No Abstract] [Full Text] [Related]
2. [Changes in blood lipid levels after the lipid tolerance test in patients with vascular diseases]. Miti L; Sprovieri G; Breschi L; Foschi F Minerva Med; 1975 Oct; 66(65):3406-27. PubMed ID: 1178134 [No Abstract] [Full Text] [Related]
3. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis]. Caruzzo C; Enrico-Bena L; Carnaghi R Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941 [No Abstract] [Full Text] [Related]
4. [Value of determining serum cholesterol levels in patients with coronary heart disease]. Stalenhoef AF Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153 [TBL] [Abstract][Full Text] [Related]
5. [Abnormal lipid metabolism and coronary insufficiency]. Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347 [No Abstract] [Full Text] [Related]
6. [Therapeutic influence on the blood lipids in manifest coronary sclerosis]. Aschenbeck G Rev Bras Med; 1971 Dec; 28(12):653-8. PubMed ID: 4259647 [No Abstract] [Full Text] [Related]
7. [Clinical experimental lipid metabolism studies with essential phospholipids taking into account the arteriosclerosis problem]. Hammerl H; Pichler O; Studlar M Wien Med Wochenschr; 1966 Apr; 116(16):348-52. PubMed ID: 5985190 [No Abstract] [Full Text] [Related]
8. [Use of the complex method of Il'k, Dodik and Iovanovich for diagnosis of humoral lipid disorders in coronary atherosclerosis]. Fomina LF; Sulava SG; Sulava PV Ter Arkh; 1968 Jun; 40(6):61-3. PubMed ID: 5739211 [No Abstract] [Full Text] [Related]
9. [The fatty acid composition of serum lipids in atherosclerosis]. Alimova EK; Endakova EA Vopr Med Khim; 1970; 16(3):310-6. PubMed ID: 5455888 [No Abstract] [Full Text] [Related]
11. [The effect of a preparation containing unsaturated fatty acids on the course of experimental atherosclerosis in rabbits]. Angarskaia MA; Sokolova VE; Liubartseva LA Farmakol Toksikol; 1972; 35(6):704-7. PubMed ID: 4651805 [No Abstract] [Full Text] [Related]
12. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis]. Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081 [No Abstract] [Full Text] [Related]
13. [Effect of gypsozide on the course of experimental cholesterol atherosclerosis in rabbits]. Iatsyno AI Farmakol Toksikol; 1969; 32(6):687-9. PubMed ID: 5393461 [No Abstract] [Full Text] [Related]
14. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases]. Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846 [No Abstract] [Full Text] [Related]